Z

Zynerba Pharmaceuticals Inc
F:6ZY

Watchlist Manager
Zynerba Pharmaceuticals Inc
F:6ZY
Watchlist
Price: 1.26 EUR 2.44% Market Closed
Market Cap: 67.6m EUR

Operating Margin
Zynerba Pharmaceuticals Inc

0%
Current
0%
Average
5.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-38.8m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Zynerba Pharmaceuticals Inc
Glance View

Market Cap
68m EUR
Industry
Pharmaceuticals

Zynerba Pharmaceuticals, Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. The company is headquartered in Devon, Pennsylvania and currently employs 28 full-time employees. The company went IPO on 2015-08-05. Cannabinoids are a class of compounds derived from Cannabis plants. Its two primary cannabinoids contained in cannabis are cannabidiol and tetrahydrocannabinol (THC). The firm is developing Zygel, the pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery and manufactured without the presence of THC. Zygel is being developed as a clear gel with once- or twice-daily dosing and is targeting the treatment of behavioral symptoms of FXS, ASD and 22q. The company has evaluated Zygel targeting the reduction of seizures in patients with a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies (DEE).

6ZY Intrinsic Value
Not Available
Z
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-38.8m
/
Revenue
0
What is the Operating Margin of Zynerba Pharmaceuticals Inc?

Based on Zynerba Pharmaceuticals Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top